REGN
REGENERON PHARMACEUTICALS, INC.Sector: Healthcare · Industry: Drug Manufacturers - General · Data as of 2026-02-04
REGENERON PHARMACEUTICALS, INC. is unresolved: one screen did not pass.
It clears the financial screens: debt vs. market cap is 3.06% against a 33% limit, and cash & interest-bearing assets vs. market cap is 29.06% against a 33% limit. Nothing in the arithmetic is close to a threshold.
Interest income not separately disclosed and cash position is elevated (29.1% ≥ 20% of market cap). Cannot safely assert compliance; manual review required.
- Undisclosed interest income + elevated cash position (cash+securities / market cap = 29.1% ≥ 20%); manual check required.
Screening standard
The evidence
| Test | Figure | Limit | Source |
|---|---|---|---|
| Passed: Business activityBusiness activity is compliant. | compliant | ||
| Passed: Debt vs. market capinterest-bearing debt / market cap = 3.06% (< 33% limit). | 3.06% | < 33.00% | |
| Failed: Interest income vs. revenueInterest income not separately disclosed and cash position is elevated (29.1% ≥ 20% of market cap). Cannot safely assert compliance; manual review required. | not compliant | ||
| Passed: Cash & interest-bearing assets vs. market cap(cash + interest-bearing securities) / market cap = 29.06% (< 33% limit). | 29.06% | < 33.00% |
Every number, sourced
Figures read directly from SEC EDGAR XBRL facts. Don't trust us — verify.
| Figure | Value | Source |
|---|---|---|
| Total revenueRevenue from contract with customer excluding assessed tax | $14.3B | |
| Interest-bearing debtLong term debt noncurrent | $2.0B | |
| Cash & interest-bearing securities3 components | $18.9B | |
| Total assetsAssets | $40.6B | |
| ReceivablesAccounts receivable net current | $5.7B | |
| Shares outstandingEntity common stock shares outstanding | 94.0M shares | |
| Priceyahoo:24mo-trailing-avg | $690.92 |
Price
Values & Controversies
Separate from the shariah verdict above — always.
No flags. This company isn't on the BNC (Boycott National Committee) priority or divestment lists, or any grassroots BDS-supported campaign we line.